NK Cell Effector Functions Regulation by Modulating nTreg Cell Population During Progressive Growth of Dalton’s Lymphoma in Mice

References

• Azimi M, Aslani S, Mortezagholi S, et al. (2016). Identification, isolation, and functional assay of regulatory T cells. Immunol Invest, 45, 584–602.
   PubMed Web of Science ®Google Scholar
• Bottino C, Castriconi R, Moretta L, et al. (2005). Cellular ligands of activating NK receptors. Trends Immunol, 26, 221–26.
   Google Scholar
• Chen W, Jin W, Hardegen N, et al. (2003). Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med, 198, 1875–86.
   Google Scholar
• Colucci F, Caligiuri MA, Di Santo JP. (2003). What does it take to make a natural killer? Nat Rev Immunol, 3, 413–25.
   Google Scholar
• Cullen SP, Brunet M, Martin SJ. (2010). Granzymes in cancer and immunity. Cell Death Differ, 17, 616–23.
   PubMed Web of Science ®Google Scholar
• Darrasse-Jeze G, Podsypanina K. (2013). How numbers, nature, and immune status of foxp3(+) regulatory T-cells shape the early immunological events in tumor development. Front Immunol, 4, 292.
   PubMed Web of Science ®Google Scholar
• De Sanctis JB, Blanca I, Bianco NE. (1997). Secretion of cytokines by natural killer cells primed with interleukin-2 and stimulated with different lipoproteins. Immunology, 90, 526–33.
   PubMed Web of Science ®Google Scholar
• Di Santo JP. (2006). Natural killer cell developmental pathways: a question of balance. Nat Rev Immunol, 24, 257–86.
   Google Scholar
• Fauriat C, Long EO, Ljunggren HG, et al. (2010). Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood, 115, 2167–76.
   PubMed Web of Science ®Google Scholar
• French AR, Yokoyama WM. (2004). Natural killer cells and autoimmunity. Arthritis Res Ther, 6, 8–14.
   PubMed Web of Science ®Google Scholar
• Gajewski TF, Schell SR, Nau G, et al. (1989). Regulation of T-cell activation: differences among T-cell subsets. Immunol Rev, 111, 79–110.
   Google Scholar
• Gameiro J, Nagib P, Verinaud L. (2010). The thymus microenvironment in regulating thymocyte differentiation. Cell Adh Migr, 4, 382–90.
   PubMed Web of Science ®Google Scholar
• Gautam PK, Maurya BN, Kumar S, et al. (2013). Progressive growth of a murine T cell lymphoma alters population kinetics and cell viability of macrophages in a tumor-bearing host. Tumour Biol, 34, 827–36.
   PubMed Web of Science ®Google Scholar
• Gupta RK, Pandey R, Sharma G, et al. (2013). DNA binding and anti-cancer activity of redox-active heteroleptic piano-stool Ru(II), Rh(III), and Ir(III) complexes containing 4-(2-methoxypyridyl) phenyldipyrromethene. Inorg Chem, 52, 3687–98.
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Schmitt E. (2003). The regulatory T cell family: distinct subsets and their interrelations. J Immunol, 171, 6323–27.
   Google Scholar
• Kerdiles Y, Ugolini S, Vivier E. (2013). T cell regulation of natural killer cells. J Exp Med, 210, 1065.
   Google Scholar
• Kubiczkova L, Sedlarikova L, Hajek R, et al. (2012). TGF-beta - an excellent servant but a bad master. J Transl Med, 10, 183.
   Google Scholar
• Kubota A, Lian RH, Lohwasser S, et al. (1999). IFN-gamma production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC class I molecules. J Immunol, 163, 6488–93.
   PubMed Web of Science ®Google Scholar
• Kumar A, Singh SM. (1996). Effect of tumor growth on the blastogenic response of splenocytes: a role of macrophage derived nitric oxide. Immunol Invest, 25, 413–23.
   PubMed Web of Science ®Google Scholar
• Kumar S, Tomar MS, Acharya A. (2015a). Carboxylic group-induced synthesis and characterization of selenium nanoparticles and its anti-tumor potential on Dalton’s lymphoma cells. Colloids Surf B Biointerfaces, 1, 546–52.
   Google Scholar
• Kumar S, Tomar MS, Acharya A. (2015b). Chelerythrine delayed tumor growth and increased survival duration of Dalton’s lymphoma bearing BALB/c H(2d) mice by activation of NK cells in vivo. J Cancer Res Ther, 11, 904–10.
   PubMed Web of Science ®Google Scholar
• Kumar S, Tomar MS, Acharya A. (2015c). Activation of p53-dependent/-independent pathways of apoptotic cell death by chelerythrine in a murine T cell lymphoma. Leuk Lymphoma, 56, 1846–55.
   PubMed Web of Science ®Google Scholar
• Lamas A, Lopez E, Carrio R, et al. (2016). Adipocyte and leptin accumulation in tumor-induced thymic involution. Int J Mol Med, 37, 133–38.
   PubMed Web of Science ®Google Scholar
• Larsen SK, Gao Y, Basse PH. (2014). NK cells in the tumor microenvironment. Crit Oncog, 19, 91–105.
   PubMedGoogle Scholar
• Li MO, Flavell RA. (2008). TGF-beta: a master of all T cell trades. Cell, 134, 392–404.
   PubMed Web of Science ®Google Scholar
• Liu C, Yu S, Kappes J, et al. (2007). Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood, 109, 4336–42.
   PubMed Web of Science ®Google Scholar
• Ljunggren HG, Karre K. (1990). In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today, 11, 237–44.
   PubMedGoogle Scholar
• Long EO, Kim HS, Liu D, et al. (2013). Controlling NK cell responses: integration of signals for activation and inhibition. Annu Rev Immunol, 31, 227–58.
   PubMed Web of Science ®Google Scholar
• Ma GF, Miao Q, Liu YM, et al. (2014). High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment. Br J Cancer, 110, 1552–60.
   PubMed Web of Science ®Google Scholar
• Mason S, Roshan R. (2002). Increased tumor necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage cancers. Immunol Invest, 31, 137–153.
   Google Scholar
• Middleton D, Curran M, Maxwell L. (2002). Natural killer cells and their receptors. Transpl Immunol, 10, 147–64.
   PubMed Web of Science ®Google Scholar
• Moretta A, Bottino C, Vitale M, et al. (2001). Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol, 19, 197–223.
   PubMed Web of Science ®Google Scholar
• Orange JS, Ballas ZK. (2006). Natural killer cells in human health and disease. Clin Immunol, 118, 1–10.
   PubMed Web of Science ®Google Scholar
• Pegram HJ, Andrews DM, Smyth MJ, et al. (2011). Activating and inhibitory receptors of natural killer cells. Immunol Cell Biol, 89, 216–24.
   PubMed Web of Science ®Google Scholar
• Rolle A, Pollmann J, Cerwenka A. (2013). Memory of infections: an emerging role for natural killer cells. PLoS Pathog, 9, 9.
   PubMed Web of Science ®Google Scholar
• Roncador G, Brown PJ, Maestre L, et al. (2005). Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol, 35, 1681–91.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Wing K, Onishi Y, et al. (2009). Regulatory T cells: how do they suppress immune responses? Int Immunol, 21, 1105–11.
   Google Scholar
• Shanker A, Singh SM, Sodhi A. (2000). Ascitic growth of a spontaneous transplantable T cell lymphoma induces thymic involution. 2. Induction of apoptosis in thymocytes. Tumour Biol, 21, 315–27.
   PubMed Web of Science ®Google Scholar
• Smyth MJ, Teng MW, Swann J, et al. (2006). CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol, 176, 1582–87.
   Google Scholar
• Wang H, Zheng X, Wei H. (2012). Important role for NKp30 in synapse formation and activation of NK cells. Immunol Invest, 41, 367–81.
   Google Scholar
• Yan H, Ding CG, Tian PX, et al. (2009). Magnetic cell sorting and flow cytometry sorting methods for the isolation and function analysis of mouse CD4+ CD25+ Treg cells. J Zhejiang Univ Sci B, 10, 928–32.
   PubMed Web of Science ®Google Scholar